newsfilter
← Latest News
FDA Approved Drugs·

Approval of Kisqali, Nda #209092 (Efficacy)

Approval Date: 07/01/2026; Drug Name: Kisqali, Nda #209092; Active Ingredients: RIBOCICLIB SUCCINATE; Company: Novartis; Submission Status: Approval; Submission Classification: Efficacy; Application Number: 209092

Company
NOVARTIS
Keywords
NOVARTIS